C5 nephritic factors drive the biological phenotype of C3 glomerulopathies-Reference-Cited by-同舟云学术

C5 nephritic factors drive the biological phenotype of C3 glomerulopathies

Published:2017-11 Issue:5 Volume:92 Page:1232-1241
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Marinozzi Maria-Chiara,Chauvet Sophie,Le Quintrec Moglie,Mignotet Morgane,Petitprez Florent,Legendre Christophe,Cailliez Mathilde,Deschenes Georges,Fischbach Michel,Karras Alexandre,Nobili Francois,Pietrement Christine,Dragon-Durey Marie-Agnes,Fakhouri Fadi,Roumenina Lubka T.,Fremeaux-Bacchi Veronique

Publisher

Elsevier BV

Subject

Nephrology

Reference29 articles.

1. C3 glomerulopathy: consensus report;Pickering;Kidney Int,2013

2. Histopathology of MPGN and C3 glomerulopathies;Cook;Nat Rev Nephrol,2015

3. Membranoproliferative glomerulonephritis–a new look at an old entity;Sethi;N Engl J Med,2012

4. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies;Servais;Kidney Int,2012

5. Complement System Part I - Molecular Mechanisms of Activation and Regulation;Merle;Front Immunol,2015

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement and systemic lupus erythematosus;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. A Cell-Based Assay to Measure the Activity of the Complement Convertases;Kidney International Reports;2024-07

3. Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy;Kidney International Reports;2024-06

4. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Kidney International;2024-06

5. Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy;Journal of the American Society of Nephrology;2024-05-06